DELTAMAXX DMX181650-20Recalls & reported problems
Medos International Sàrl · DELTAMAXX microcoil DELTAMAXX 18 Stretch Resistant Coil 16mm x 50cm 190cm Contents: 1 Detachable Coil System Coil Type: DELTAMAXX 18 Stretch Resistant Coil · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10878528001819), received between Jul 25, 2019 and Jul 25, 2019 — classified as 1 injury.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Migration1
Patient problems
- No Code Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJul 25, 2019Detachment of Device or Device Component; Migration; Detachment of Device or Device Component; Migration
AS REPORTED BY A HEALTHCARE PROFESSIONAL, DURING A COIL EMBOLIZATION OF AN INTRACRANIAL PIAL ARTERIOVENOUS FISTULA (PAVF), A 16X50 DELTAMAXX (DMX18165020/C32802) COIL ¿PULLED AWAY SPONTANEOUSLY AND PREMATURELY FROM THE CATHETER¿. THE INCIDENT OCCURRED AT THE BASILAR ARTERY, AND THE COIL MOVED ECTOPICALLY FROM THE FISTULA LOCATION TO THE VERTEBRAL ARTERY. THERE WAS AN IMMEDIATE ATTEMPT MADE TO REMOVE THE COIL INTRA-ARTERIALLY AND INTRA-VENOUSLY; HOWEVER, ONLY PARTIAL REMOVAL OF THE COIL COULD BE PERFORMED. THE PROCEDURE WAS STOPPED, AND THE MALFORMATION COULD NOT BE TREATED. NO PATIENT COMPLICATIONS OCCURRED AS A RESULT OF THE EVENT, BUT ANTIPLATELET THERAPY WAS INITIATED DURING THE PROCEDURE. NO FURTHER INFORMATION WAS REPORTED AT THE TIME OF COMPLAINT INITIATION.
Patient problems: No Code Available
MAUDE report 8826640 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page